MICHIGAN MEDICAL DEVICE SUMMIT - JUNE 16, 2021 - REGISTER NOW

We Help Michigan Bioscience DEFINE THE FUTURE

Empowering the nearly 40,000 people and 1,800 companies in Michigan's bio-industry as they change, improve, and save lives.

LEARN MORE

OUR MISSION

We drive bio-industry growth in Michigan to create the next generation of bio-innovation.

MichBio proudly serves the following bio-industry sectors:

Agri-Biosciences

Medical Device

Pharma

R&D/Testing

Informatics/Health IT

Logistics

Connect

Industry collaboration is key to creating synergy and driving innovation - we host events, share stories, and tap into our extensive networks and connections to national organizations to help you create the relationships that will help your business grow.

Advocate

You don't have the time or resources to visit the state or federal legislature every time a bill is proposed that might impact your business - that's why we go for you.

Educate

Empower

Your business is only as strong as the resources that support it. From legal aid or marketing support to referrals, and a purchasing program that gives you the buying power of a major corporation, we have solutions to empower you.

MORE MEMBER BENEFITS

EVENTS

EU Clinical Trials Regulation: The Clinical Trial Transparency Revolution

MMS Holdings – an award-winning, data-focused CRO – is hosting a webinar on the new EU Clinical Trials Regulation as part of our Expert Insights Webinar series. Abstract: The EU Clinical Trials Regulation (Regulation No 536/2014) will enter in force in January 2022, changing clinical trial processes in Europe and impacting clinical trial activities…

NEWS

Contract research firm Kalexsyn names Brian Eklov as CEO

June 1, 2021

KALAMAZOO — Contract research organization Kalexsyn Inc. has named Brian Eklov as CEO. Eklov, who’s been with the Kalamazoo-based Kalexsyn since 2007, succeeds retiring co-founder Robert Gadwood as CEO. His appointment was effective Tuesday. Brian EklovCOURTESY PHOTO Eklov “has deep knowledge of the industry dynamics and has been an outstanding R&D director at Kalexsyn since 2016,” said Jorge Nogueira, chairman of Kalexsyn’s…

Cayman Develops Powerful Multiplex ELISA for Autoantibody Detection

June 1, 2021

ANN ARBOR, MI, May 11, 2021 — Cayman Chemical’s new Q-Plex™ Autoantibody Detection 10-Plex Panel, developed in collaboration with Quansys Biosciences, offers standardized, multiplex capabilities for the concurrent analysis of ten prominent analytes associated with rheumatoid arthritis or other autoimmune diseases. This new qualitative, chemiluminescent ELISA measures human antibodies against PAD3, PAD4, fibrinogen, citrullinated fibrinogen, carbamylated fibrinogen, human core histones,…

The Big Pharma CEO Who’s Helping to Put an End to COVID-19

June 1, 2021

Most Americans don’t know his name. Before the announcement that his company had come up with a vaccine for COVID-19 that was 95 percent effective and was primed to manufacture millions of doses, fewer still knew much about the company he led—Pfizer—other than this: They didn’t like it. Or the industry in which he spent his life working. Indeed, by…

MORE NEWS